Deflazacort Oral Suspension
NDC 81806-200, Deflazacort, suspension, from Doppel Farmaceutici S.r.l..
- Product NDC
- 81806-200
- Status
- Listed
- Labeler
- Doppel Farmaceutici S.r.l.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA220042
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81806-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEFLAZACORT22.75 mg/mL
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81806-200-73 | 81806020073 | 1 BOTTLE in 1 CARTON (81806-200-73) / 13 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/40a833a4-e029-a99e-e063-6394a90afd50
Use it
Look up 81806-200 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81806-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81806-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.